Funding for this research was provided by:
Deutsche Krebshilfe (70112888, 70112888)
Bundesministerium für Bildung und Forschung (e:Med Initiative; 01ZX1901A)
Article History
Received: 22 June 2020
Revised: 15 September 2020
Accepted: 2 October 2020
First Online: 15 October 2020
Compliance with ethical standards
:
: MLS is a founder and shareholder of PearlRiver Bio GmbH and receives a research grant from PearlRiver Bio GmbH. HLT is a consultant for PearlRiver Bio GmbH.